Cathie Wood acquired 2.01 Million Arcturus Therapeutics Holdings shares worth $23.7 Million. That's 0.21% of their equity portfolio (59th largest holding). The investor owns 7.18% of the outstanding Arcturus Therapeutics Holdings stock. The first Arcturus Therapeutics Holdings trade was made in Q4 2019. Since then Cathie Wood bought shares eight more times and sold shares on thirteen occasions. The investor's estimated purchase price is $75.5 Million, resulting in a loss of 69%.